About |
BioAMPs International is a Colorado-based biotechnology company that discovers and develops proprietary, structurally-guided antimicrobial peptides that are designed to target bacterial cell membranes while sparing human blood and tissue cells. The de novo peptides are structurally designed to alter hydrophobicity characteristics, thus creating a unique mechanism of action that targets the bacterial cell membrane, providing broad-spectrum activity and circumventing all known routes of drug resistance experienced by traditional antibiotics.